OBJECTIVE: Although hypomagnesemia reduces insulin sensitivity, benefits of magnesium supplementation to non-diabetic insulin resistant subjects has not been established. Our purpose was to determine whether oral magnesium supplementation with magnesium chloride (MgCl2) 2.5 g daily modify insulin sensitivity in non-diabetic subjects. MATERIAL AND METHODS: This study was a 3 months randomized double-blind placebo-controlled trial. Apparently healthy subjects were eligible to participate if they had insulin resistance (HOMA-IR index equal or greater than 3.0) and hypomagnesemia (Serum magnesium levels equal or lower than 0.74 mmol/l). Subjects were randomized to receive either, MgCl2 2.5 g daily or placebo by 3-months. RESULTS: At baseline there were not significant anthropometric or laboratory differences between both groups. At ending of the study, magnesium-supplemented subjects significantly increased their serum magnesium levels (0.61 +/- 0.08 to 0.81 +/- 0.08 mmol/l, p<0.0001) and reduced HOMA-IR index (4.6 +/- 2.8 to 2.6 +/- 1.1, p<0.0001), whereas control subjects did not (0.62 +/- 0.08 to 0.61 +/- 0.08 mmol/l, p=0.063 and 5.2 +/- 1.9 to 5.3 +/- 2.9, p=0.087). CONCLUSIONS:Oral magnesium supplementation improves insulin sensitivity in hypomagnesemic non-diabetic subjects. Clinical implications of this finding have to be established.
RCT Entities:
OBJECTIVE: Although hypomagnesemia reduces insulin sensitivity, benefits of magnesium supplementation to non-diabetic insulin resistant subjects has not been established. Our purpose was to determine whether oral magnesium supplementation with magnesium chloride (MgCl2) 2.5 g daily modify insulin sensitivity in non-diabetic subjects. MATERIAL AND METHODS: This study was a 3 months randomized double-blind placebo-controlled trial. Apparently healthy subjects were eligible to participate if they had insulin resistance (HOMA-IR index equal or greater than 3.0) and hypomagnesemia (Serum magnesium levels equal or lower than 0.74 mmol/l). Subjects were randomized to receive either, MgCl2 2.5 g daily or placebo by 3-months. RESULTS: At baseline there were not significant anthropometric or laboratory differences between both groups. At ending of the study, magnesium-supplemented subjects significantly increased their serum magnesium levels (0.61 +/- 0.08 to 0.81 +/- 0.08 mmol/l, p<0.0001) and reduced HOMA-IR index (4.6 +/- 2.8 to 2.6 +/- 1.1, p<0.0001), whereas control subjects did not (0.62 +/- 0.08 to 0.61 +/- 0.08 mmol/l, p=0.063 and 5.2 +/- 1.9 to 5.3 +/- 2.9, p=0.087). CONCLUSIONS: Oral magnesium supplementation improves insulin sensitivity in hypomagnesemic non-diabetic subjects. Clinical implications of this finding have to be established.
Authors: Leo A Celi; Daniel J Scott; Joon Lee; Rachel Nelson; Seth L Alper; Kenneth J Mukamal; Roger G Mark; John Danziger Journal: J Hypertens Date: 2013-11 Impact factor: 4.844
Authors: Rebecca B Costello; Ronald J Elin; Andrea Rosanoff; Taylor C Wallace; Fernando Guerrero-Romero; Adela Hruby; Pamela L Lutsey; Forrest H Nielsen; Martha Rodriguez-Moran; Yiqing Song; Linda V Van Horn Journal: Adv Nutr Date: 2016-11-15 Impact factor: 8.701
Authors: Adela Hruby; Julius S Ngwa; Frida Renström; Mary K Wojczynski; Andrea Ganna; Göran Hallmans; Denise K Houston; Paul F Jacques; Stavroula Kanoni; Terho Lehtimäki; Rozenn N Lemaitre; Ani Manichaikul; Kari E North; Ioanna Ntalla; Emily Sonestedt; Toshiko Tanaka; Frank J A van Rooij; Stefania Bandinelli; Luc Djoussé; Efi Grigoriou; Ingegerd Johansson; Kurt K Lohman; James S Pankow; Olli T Raitakari; Ulf Riserus; Mary Yannakoulia; M Carola Zillikens; Neelam Hassanali; Yongmei Liu; Dariush Mozaffarian; Constantina Papoutsakis; Ann-Christine Syvänen; André G Uitterlinden; Jorma Viikari; Christopher J Groves; Albert Hofman; Lars Lind; Mark I McCarthy; Vera Mikkilä; Kenneth Mukamal; Oscar H Franco; Ingrid B Borecki; L Adrienne Cupples; George V Dedoussis; Luigi Ferrucci; Frank B Hu; Erik Ingelsson; Mika Kähönen; W H Linda Kao; Stephen B Kritchevsky; Marju Orho-Melander; Inga Prokopenko; Jerome I Rotter; David S Siscovick; Jacqueline C M Witteman; Paul W Franks; James B Meigs; Nicola M McKeown; Jennifer A Nettleton Journal: J Nutr Date: 2013-01-23 Impact factor: 4.798
Authors: Daniel T Dibaba; Pengcheng Xun; Yiqing Song; Andrea Rosanoff; Michael Shechter; Ka He Journal: Am J Clin Nutr Date: 2017-07-19 Impact factor: 7.045
Authors: Liza A H Rosén; Lorena O Blanco Silva; Ulrika K Andersson; Cecilia Holm; Elin M Ostman; Inger M E Björck Journal: Nutr J Date: 2009-09-25 Impact factor: 3.271